Novartis AG
novartis.comWhat Do They Do?
Sells prescription medicines for patients with a range of diseases, primarily to wholesalers, healthcare systems and public or private healthcare payers.
20-F for FY2025, filed Feb 4, 2026
Who Are Their Customers?
Novartis sells mainly to drug wholesalers and retailers, alongside health systems and public or private healthcare payers. Its representatives also reach physicians, pharmacists, hospitals and other health professionals.
20-F for FY2025, filed Feb 4, 2026
20-F for FY2025, filed Feb 4, 2026
The Company’s largest, second-largest and third-largest customers account for approximately 18%, 13% and 7% of net sales from third parties…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 25 cents of every revenue dollar as net income in .
20-F for FY2025, filed Feb 4, 2026
How Are They Changing?
Portfolio description
The older report described both pharmaceuticals and cost-saving generic medicines; the latest describes a company engaged in research, development, manufacturing, distribution, marketing and sale of pharmaceutical products.
20-F for FY2022, filed Feb 1, 2023 20-F for FY2025, filed Feb 4, 2026Novartis is a multinational group of companies specializing in the research, development, manufacturing and marketing of a broad range of…View ↗
Novartis is an innovative medicines company, engaged in the research, development, manufacturing, distribution, marketing and sale of a…View ↗
Loading...
